Shay Capital LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Shay Capital LLC

  • $640 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $419,050 - $495,000
5,000 New
5,000 $436,000
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $1.19 Million - $1.48 Million
-16,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $1.15 Million - $1.46 Million
16,000 New
16,000 $1.41 Million

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email